Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (11107)	5/8/2017 1:37:54 PM
From: tuck	Read Replies (2) \| Respond to of 12215

Somewhere around here, you asked if I still had my bone pile shares in some company. Without searching, I'm pretty sure I was referring to Corbus. I think you last said you were holding 10% of your original position in that one, about two months ago. I was wondering what you thought of that moonshot now that some more equivocally positive data is in. I'm also trying to focus more in biotech. I hold positions in FGEN, TRIL, CARA, MNTA, MGNX, and JUNO - the last two added today. I've been in and out of ADXS a lot (currently out, but would reload under $7.90, which is getting close) for modest gains. I watch some others with less intensity, for possible summer shopping: XNCR, BLCM, BPMC, PIRS, RXDX (tried for a position, but was afraid to get in in front of pricing of secondary, as that nearly burned me with CARA), for example. Speaking of which, CARA's become my second largest position, and it's been quite a fade on a total lack of news. Makes me wonder what folks are afraid of that they weren't a month ago. Way below the secondary pricing now. Cheers, Tuck